Ata uhi

Novel Challenges and Therapeutic Options for Liver Diseases

This Special Issue focuses on cutting-edge developments, from viral diseases via autoimmune, vascular, metabolic disorders, to liver cirrhosis and its complications, such as acute and chronic hepatic failure and the development of primary liver cell carcinoma. Digitalization, prevention, and telemed...

Whakaahuatanga katoa

I tiakina i:
Hōputu: Online
Reo:Ingarihi
I whakaputaina: MDPI - Multidisciplinary Digital Publishing Institute 2024
Ngā marau:
microbiome
obesity
metabolic syndrome
fecal microbiota transplantation
ROTEM®
TIPS
liver disease
thrombosis risk assessment
hypercoagulable state
portal hypertension
hepatic decompensation
chronic hepatitis B
chronic hepatitis C
chronic hepatitis D
antiviral therapy
liver cirrhosis
DAA therapy
functional cure
HBsAg loss
hepatology
liver transplantation
decompensated cirrhosis
acute-on-chronic liver failure
NASH
pNRF2
SOCS3
immunohistochemistry
UDCA
bile acid transporter
ALT
GGT
TE
neuroendocrine
transplantation
outcomes
liver metastases
systematic review
prevention
management
telemedicine
metabolic dysfunction-associated fatty liver disease
monitor
lifestyle modification
COVID-19 pandemic
NUC treatment
low-level HBsAg carriers
therapeutic vaccination
third generation pre-S/S vaccine
long-term observation
hepatocellular carcinoma
HCC
MASLD
MASH
NAFLD
biomarker
intestinal microbiota
chronic hepatitis b
HBsAg seroconversion
seroclearance
history of hepatology
MASLD/NAFLD
liver fibrosis/cirrhosis
chronic viral hepatitides
liver–microbiome axis
organokine crosstalk
chronobiology
liver aging
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
Urunga tuihono:ONIX_20240704_9783725815289_233
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

ONIX_20240704_9783725815289_233

Ngā tūemi rite